Jane Street’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Jane Street’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-353,219	Closed	-$3.54M	–	10829
2022 Q3	$3.54M	Buy	353,219 +10,877	+3%	+$108K	﹤0.01%	3194
2022 Q2	$3.39M	Buy	342,342 +296	+0.1%	+$2.92K	﹤0.01%	3246
2022 Q1	$3.37M	Sell	342,046 -135	-0%	-$1.33K	﹤0.01%	3718
2021 Q4	$3.35M	Sell	342,181 -178	-0.1%	-$1.75K	﹤0.01%	3511
2021 Q3	$3.36M	Buy	342,359 +6,447	+2%	+$63.5K	﹤0.01%	3445
2021 Q2	$3.32M	Buy	335,912 +150,485	+81%	+$1.51M	﹤0.01%	3398
2021 Q1	$1.9M	Buy	+185,427	New	+$2.06M	﹤0.01%	4116

Jane Street's LUXA Position: Q4 2022 in Review

Jane Street sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 353,219 shares — an estimated $3.54M sold.

Jane Street first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $3.54M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Jane Street reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Jane Street sold 353,219 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $3.54M.
Jane Street first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
Jane Street's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $3.54M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.